Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Signe FoghsgaardLouise VedtofteEmilie S AndersenEmilie BahneCamilla AndreasenAnne L SørensenJulie Lyng FormanElisabeth Reinhardt MathiesenJens A SvareTine D ClausenPeter DammJens Juul HolstFilip K Krag KnopTina VilsbøllPublished in: Diabetes, obesity & metabolism (2023)
Treatment with liraglutide for 52 weeks improved glucose tolerance, FPG, HbA1c and bodyweight in women with overweight/obesity and pGDM. Progression to prediabetes while on drug was markedly reduced, but after a 1-week drug wash-out, the effect was lost.